JCVI Statement on flu vaccines for 2023-24

This is JVCI guidance NOT NHS England reimbursement

JVCI has reviewed the latest evidence on Influenza vaccines and published their recommendations for the 2023/24 season. The advice in the link below represents the JVCI’s scientific view on the use of influenza vaccines in the UK for the 2023/24 influenza season. NHSE is yet to publish the flu reimbursement letter for 2023/24. 

Pharmacies are advised that if they place orders before the NHSE reimbursement letter, they do so at risk. Please make sure that all such orders are fully cancellable. 

QIVe is listed as a 3^rd line vaccine and may be used only when the recommended 1^st and 2^nd line vaccines are not available, and it is not recommended for >65 years. 

Full JCVI statement can be found here:

• Draft JCVI Statement on Influenza Vaccines 2023-24_final version.pdf | Powered by Box

Summary table influenza vaccines for 2023/24

† LAIV the vaccine of choice for the children’s programme 2-17 year olds
‡ A temporary cohort during the COVID -19 pandemic influenza 2020/21, 2021/22 and
2022/23 seasons. Policy for 2023/24 to be confirmed.